Two firms to distribute dry eye therapy
June 22nd 2011OCuSOFT, Inc. and Ardeo Health, LLC have entered into an exclusive, multi-year agreement to distribute a dry eye therapy under license from Novagali Pharma S.A. of Evry, France. The therapy, Nova23041, will be marketed and distributed in the U.S. and Canada as Retaine MGD Ophthalmic Emulsion under a brand license from OCuSOFT, Inc. The preservativefree, oilinwater emulsion will be targeted for individuals suffering from meibomian gland dysfunction.
Mitosol gains refractive indication
June 22nd 2011A preparation of ophthalmic mitomycin (Mitosol, Mobius Therapeutics) has received a third orphan drug designation from the FDA. This indication is for use in preventing corneal haze following surface ablation laser keratectomy, and adds a refractive indication to two previous orphan drug designations for the product: glaucoma and pterygium.
Panel recommends aflibercept for wet AMD treatment
June 22nd 2011Aflibercept ophthalmic solution (Eylea, Regeneron) has received a unanimous recommendation from the Dermatologic and Ophthalmic Drugs Advisory Committee of the FDA for the treatment of the neovascular (wet) form of age-related macular degeneration (AMD).
Power, phaco time reduced in second half of surgery
June 15th 2011The venturi vacuum modality associated with a proprietary phacoemulsification system seems to be more efficient than its counterpart peristaltic system, with reductions in power and phaco time of 20% and 14% respectively, in 104 cases.
System for cataract surgery nets positive initial outcomes
June 15th 2011Intra-operative use of on-screen image guidance with a high-definition three-dimensional surgical microscope system is showing promise for improving the precision and predictability of various maneuvers during small-incision cataract surgery.
Investigational drug voclosporin safe, effective for noninfectious uveiti
June 15th 2011The investigational drug voclosporin has shown positive effects compared with placebo in the management of uveitis in pivotal phase III clinical trials as an oral corticosteroid-sparing drug in patients with clinically quiescent noninfectious uveitis.
Cataract surgery benefits from femtosecond laser
June 15th 2011Femtosecond laser-assisted cataract surgery seems to be a major step forward as a result of the added safety and precision that the laser confers, such as to the creation of the incision, relaxing incisions, capsulorhexis, and nuclear removal steps.
Bandage for cataract surgery patients meets primary endpoints in U.S. trial
June 15th 2011Results of a randomized, controlled U.S. pivotal trial of cataract surgery patients confirmed the efficacy and safety of a novel topical ocular bandage for protecting clear corneal incisions and minimizing postoperative pain.